Silence Therapeutics - The GOLDen future of RNAi Research - Mark Rothera, President and CEO of Silence Therapeutics 00:00:00
Mark Rothera, President and CEO of Silence Therapeutics discusses RNAi research and how the company is applying its mRNAi GOLD™ platform to precisely target and silence disease-associated genes in the liver, representing a substantial opportunity for both medicine and the company.